New Gilead hep C combo Epclusa gains FDA approval By Ben Adams Jun 28, 2016 1:49pm hepatitis C Bristol Myers Squibb Food and Drug Administration (FDA) Gilead Sciences ...
Gilead ($GILD) has proved once again that it knows how to cure hepatitis C for a heavy concentration of patients, posting some stellar pangenotype data from a slate ...
Gilead Sciences ($GILD) already reaps billions from its hep C meds Sovaldi and Harvoni, but the company isn't content to sit back with the status quo. It's prepping a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results